Skip to main content
Top
Published in: Lung 3/2020

01-06-2020 | Primary Immunodeficiency | PULMONARY INFECTIOUS DISEASE

Incidence and Risk of Pneumococcal Pneumonia in Adults with Distinct Underlying Medical Conditions: A Population-Based Study

Authors: A. Vila-Corcoles, O. Ochoa-Gondar, A. Vila-Rovira, M. Aragon, L. Esteban-Julvez, N. Chamorro, I. Hospital, E. Satue, J. Blade, C. de Diego, F. Gomez-Bertomeu, X. Raga

Published in: Lung | Issue 3/2020

Login to get access

Abstract

Purpose

This study investigated the incidence of pneumococcal pneumonia requiring hospitalisation among middle-aged and older adults with and without specific underlying medical conditions, evaluating the influence of these conditions in the risk of developing pneumonia.

Methods

Population-based prospective cohort study included 2,025,730 individuals ≥ 50 years around Catalonia, Spain. The Catalonian information system for the development of research in primary care (SIDIAP) was used to establish baseline characteristics of the cohort (comorbidities and underlying medical conditions). Hospitalisations from pneumococcal pneumonia occurred among cohort members between 01/01/2015 and 31/12/2015 were collected from hospital discharge codes of 68 reference Catalonian hospitals. Cox regression was used to estimate the association between baseline conditions and the risk of developing pneumonia.

Results

Global incidence rate (IR) of hospitalised pneumococcal pneumonia was 82.8 cases per 100,000 persons-year. Maximum IRs (per 100,000 persons-year) emerged among persons with haematological neoplasia (837.4), immunodeficiency (709.2), HIV infection (474.7), severe renal disease (407.5) and chronic pulmonary disease (305.7). In the multivariable analyses, apart from increasing age, HIV infection (hazard ratio [HR] 6.78), haematological neoplasia (HR 6.30), prior all-cause pneumonia (HR 5.27), immunodeficiency (HR 4.57) and chronic pulmonary disease (HR 2.89) were the conditions most strongly associated with an increasing risk. Pneumococcal vaccination did not emerge associated with a reduced risk in our study population (nor PPsV23 neither PCV13).

Conclusion

Old age, immunocompromising conditions and chronic pulmonary/respiratory disease are major risk factors for pneumococcal pneumonia in adults. Our data underline the need for better prevention strategies in these persons.
Appendix
Available only for authorised users
Literature
1.
10.
go back to reference Centers for Disease Control and Prevention (1997) Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 46:1–24 Centers for Disease Control and Prevention (1997) Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 46:1–24
11.
go back to reference Kyaw MH, Rose CE Jr, Fry AM et al (2005) The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis 192:377–386CrossRef Kyaw MH, Rose CE Jr, Fry AM et al (2005) The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis 192:377–386CrossRef
15.
go back to reference García-Gil MM, Hermosilla E, Prieto-Alhambra D et al (2011) Construction and validation of a scoring system for the selection of high-quality data in a Spanish population primary care database (SIDIAP). Inform Prim Care 19:135–145 García-Gil MM, Hermosilla E, Prieto-Alhambra D et al (2011) Construction and validation of a scoring system for the selection of high-quality data in a Spanish population primary care database (SIDIAP). Inform Prim Care 19:135–145
17.
go back to reference Hosmer DW, Lemeshow S (1999) Applied survival analysis. Regression modeling of time to event data. Wiley, New York Hosmer DW, Lemeshow S (1999) Applied survival analysis. Regression modeling of time to event data. Wiley, New York
27.
go back to reference Guevara RE, Butler JC, Marston BJ et al (1999) Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies. Am J Epidemiol 149:282–289CrossRef Guevara RE, Butler JC, Marston BJ et al (1999) Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies. Am J Epidemiol 149:282–289CrossRef
Metadata
Title
Incidence and Risk of Pneumococcal Pneumonia in Adults with Distinct Underlying Medical Conditions: A Population-Based Study
Authors
A. Vila-Corcoles
O. Ochoa-Gondar
A. Vila-Rovira
M. Aragon
L. Esteban-Julvez
N. Chamorro
I. Hospital
E. Satue
J. Blade
C. de Diego
F. Gomez-Bertomeu
X. Raga
Publication date
01-06-2020
Publisher
Springer US
Published in
Lung / Issue 3/2020
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-020-00349-y

Other articles of this Issue 3/2020

Lung 3/2020 Go to the issue